e-learning
resources
Milan 2017
Monday, 11.09.2017
Microbiology and laboratory techniques to monitor NTM infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Apoptosis plays a protective role against Mycobacterium avium infection in mice
M. Fujita (Fukuoka, Japan)
Source:
International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Session:
Microbiology and laboratory techniques to monitor NTM infections
Session type:
Thematic Poster
Number:
2735
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Fujita (Fukuoka, Japan). Apoptosis plays a protective role against Mycobacterium avium infection in mice. 2735
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Impaired host defense against
Mycobacterium avium
in mice with chronic granulomatous disease
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
Mycobacterium tuberculosis modulates mitochondrial function in human macrophages
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Mycobacterium avium
complex infection: phenotypes and outcomes
Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017
Year: 2017
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Autophagy modulation by
Mycobacterium tuberculosis in vitro
infection of macrophages
Source: Annual Congress 2010 - Scientific advances in tuberculosis
Year: 2010
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Pulmonary infection
with
Mycobacterium avium
in immunocompetent children without IFN-γ
(interferon-gamma)
or IL-12-receptor deficiency
Source: Eur Respir J 2001; 18: Suppl. 33, 511s
Year: 2001
Investigation of the inhibition of adherence of
Mycobacterium avium
complex (MAC) and
Mycobacterium tuberculosis
(MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001
Effect of persistent mycobacterium avium complex infection on serum vitamin D status and its regulating factors
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
In vitro susceptibility of M. avium against protionamide
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018
Bedaquiline as a potential agent in the treatment of M. intracellulare and M. avium infections
Source: Eur Respir J , 49 (3) 1601969; DOI: 10.1183/13993003.01969-2016
Year: 2017
Elucidation of Protein Tyrosine Phosphatase-B for its role in intracellular survival of Mycobacterium tuberculosis
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
On the nature of Mycobacterium tuberculosis-latent bacilli
Source: Eur Respir J 2004; 24: 1044-1051
Year: 2004
The role of genexpert in the diagnosis of mycobacterium tuberculosis
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
Infection of the respiratory mucosa by
Mycobacterium avium
complex (MAC),
Mycobacterium tuberculosis
(MTB) and
Mycobacterium smegmatis
(MS)
Source: Eur Respir J 2001; 18: Suppl. 33, 308s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept